Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection
About this item
Full title
Author / Creator
Publisher
MDPI
Journal title
Language
English
Formats
Publication information
Publisher
MDPI
Subjects
More information
Scope and Contents
Contents
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western populations. Therapies such as mRNA and siRNA encapsulated in lipid nanoparticles (LNPs) represent a clinically advanced platform and are utilized for a wide variety of applications. Unfortunately, transfection of RNA into CLL cells remains a formidable challenge and a...
Alternative Titles
Full title
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_83e4072bbf3b47538b44476755a0f20f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_83e4072bbf3b47538b44476755a0f20f
Other Identifiers
ISSN
1999-4923
E-ISSN
1999-4923
DOI
10.3390/pharmaceutics12060520
